MENU 
The summary EQA timetable can be downloaded HERE. The calendar below includes all EQA open/close dates and other GenQA events.
EQA Catalogue Groups
(Click on a colour/icon to filter calendar entries)
Clinical Genetics and Genetic Counselling
Genomic and Inherited Disorders
Haematological Neoplasms
Individual Competency Assessment
Molecular Newborn Screening
Molecular Pathology
Multidisciplinary team (MDT) working
Pharmacogenomics
Preimplantation Genetic Testing (PGT)
Reproductive Genomics
Sample Handling
Technical (Next Generation Sequencing)
Variant Classification
Viral Sequencing
Other Events
GenQA EQA Enrolment Event
GenQA EQA Distribution Event
GenQA webinar
Conference
GenQA workshop
GenQA Participant meeting
GenQA office closed
Other
| «prev September 2026 next»
| ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| Sun 30 | Mon 31
2026 Distribution 15
2026 Bone Marrow Failure syndromes (pilot) - OPENS Testing Period: 12 weeks
2026 Chronic Lymphocytic Leukaemia (CLL) - OPENS Testing Period: 6 weeks
2026 Chronic Lymphocytic Leukaemia (CLL) IGHV mutation status - OPENS Testing Period: 6 weeks
2026 Chronic Lymphocytic Leukaemia (CLL) TP53 mutation analysis - OPENS Testing Period: 6 weeks
2026 Lymphoma - OPENS Testing Period: 6 weeks
2026 Optical Genome Mapping (OGM) - haematological neoplasms (pilot) - OPENS Testing Period: 6 weeks
2026 Inherited cytopenias (pilot) - OPENS Testing Period: 12 weeks | Tue 1 | Wed 2 | Thu 3 | Fri 4 | Sat 5 |
| Sun 6 | Mon 7
2026 Distribution 16
2026 Pregnancy loss - OPENS Testing Period: 6 weeks
2026 Prenatal constitutional Copy Number Variant (CNV) detection - OPENS Testing Period: 6 weeks
2026 Prenatal karyotyping - OPENS Testing Period: 6 weeks
2026 Preimplantation genetic testing for aneuploidies (PGT-A) - OPENS Testing Period: 6 weeks
2026 Preimplantation genetic testing for structural rearrangements (PGT-SR) - OPENS Testing Period: 6 weeks | Tue 8 | Wed 9 | Thu 10 | Fri 11 | Sat 12 |
| Sun 13 | Mon 14 | Tue 15 | Wed 16 | Thu 17 | Fri 18 | Sat 19 |
| Sun 20 | Mon 21
2026 Distribution 17
2026 BRCA testing for ovarian and prostate cancer - somatic - OPENS Testing Period: 8 weeks
2026 BRCA testing for ovarian, breast, prostate and pancreatic cancer - germline - OPENS Testing Period: 8 weeks
2026 BRCA testing for prostate cancer - cfDNA - OPENS Testing Period: 8 weeks
2026 Circulating free (cf) DNA testing in lung cancer - OPENS Testing Period: 8 weeks
2026 Next Generation Sequencing (NGS) for germline CNVs (pilot) - OPENS Testing Period: Eight weeks
2026 Next Generation Sequencing (NGS) for germline SNVs and indels - OPENS Testing Period: Eight weeks
2026 Next Generation Sequencing (NGS) for somatic SNVs and indels - tumour testing only - OPENS Testing Period: Eight weeks
2026 Next Generation Sequencing (NGS) for somatic SNVs and indels - tumour with germline subtraction analysis - OPENS Testing Period: Eight weeks | Tue 22 | Wed 23 | Thu 24 | Fri 25
2026 Pharmacogenomics: Aminoglycoside ototoxicity - CLOSES
2026 Pharmacogenomics: APOE (pilot) - CLOSES
2026 Pharmacogenomics: CYP2C19 - CLOSES
2026 Pharmacogenomics: DPYD - CLOSES
2026 Pharmacogenomics: panel (pilot) - CLOSES
2026 Pharmacogenomics: TPMT and NUDT15 - CLOSES
2026 Pharmacogenomics: UGT1A1 (pilot) - CLOSES | Sat 26 |
| Sun 27 | Mon 28
2026 Distribution 18
2026 Cystic Fibrosis (CF) Molecular Newborn screening (bloodspots) - round 3 - OPENS Testing Period: 4 weeks
2026 MCADD Molecular Newborn Screening (bloodspots) - round 3 - OPENS Testing Period: 4 weeks
2026 SCID Molecular Newborn Screening (bloodspots) - round 3 - OPENS Testing Period: 4 weeks
2026 Spinal Muscular Atrophy (SMA) Molecular Newborn screening (bloodspots) - round 3 - OPENS Testing Period: 4 weeks
2026 Reproductive carrier screening (pilot) - OPENS Testing Period: 8 weeks | Tue 29 | Wed 30 | Thu 1 | Fri 2
2026 Trio Sequencing - Postnatal (neonatal and paediatric) - CLOSES
2026 Trio Sequencing - Prenatal - CLOSES
2026 SARS-CoV-2 sequencing - Distribution 6101 - round 2 - CLOSES | Sat 3 |
7872
NEWSLETTER SIGN UP